Chronic Liver Disease, Cirrhosis
Conditions
Brief summary
TARGET-Liver Disease (TARGET-LD) is an observational research study to conduct a comprehensive review of outcomes for patients with chronic liver disease (CLD).
Interventions
OTHERObservational
Observational
Sponsors
Target PharmaSolutions, Inc.
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Disease Cohort •Adult\* patients at the time of enrollment with a diagnosis of CLD/cirrhosis by ICD-10 code in the EHR interface Engaged Cohort * Adult\* patients diagnosed and managed for CLD/cirrhosis invited to participate * Ability to provide written informed consent
Exclusion criteria
Disease Cohort * Death * Manual removal (sponsor or site request) * No EHR interface encounter \> 3 years. Engaged Cohort * Patient expressed desire to withdraw consent to complete PROs * Failure to complete PROs within 24 weeks of initial invitation * Greater than 24 months lapse of survey completion after baseline surveys completed * Additionally, the criteria detailed for Disease Cohort apply to the Engaged Cohort.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To establish learning health networks focused on quality of care for patients | 20 Years |
| To characterize the natural history of disease in patients with CLD from various etiologies and Cirrhosis | 20 Years |
| To assess safety and effectiveness of CLD/Cirrhosis treatments and treatments for complications of any chronic liver disease | 20 Years |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate longitudinal and patient reported outcomes in CLD/Cirrhosis | 20 Years |
| To evaluate provider management practices in the treatment of patients with CLD/Cirrhosis | 20 Years |
Countries
United States
Outcome results
None listed